Teva Pharm Q4 profit, revenue fall as Copaxone sales drop
February 11, 2016 at 07:32 AM EST
TEL AVIV, Feb 11 (Reuters) - Teva Pharmaceutical Industries , the world's largest generics drugmaker, reported a decline in fourth-quarter profit and revenue as sales of its top drug Copaxone fell in the wake of competition.
